Imagenebio, INC. (IMA) — S-1 Filings
All S-1 filings from Imagenebio, INC.. Browse 1 IPO Filing reports with AI-powered summaries and risk analysis.
S-1 Filings (1)
-
ImageneBio Debuts on Nasdaq, Eyes $257B Immunology Market with Lead Asset IMG-007
— Sep 8, 2025 Risk: high
ImageneBio, Inc. (IMA) is a clinical-stage biopharmaceutical company focused on developing therapies for autoimmune, immunological, and inflammatory (I&I) indic
Popular Companies
AAPL · TSLA · MSFT · AMZN · GOOGL · META · NVDA · JPM · BRK-B · V · JNJ · UNH · XOM · WMT · MA · PG · HD · DIS · BAC · NFLX